Skip to content
USPeptideRxLearnApply for an account

Compliance · State rules

Office-use compounding in Arkansas

Silent for 503A pharmacies; expressly permitted for outsourcing facilities since 2025
USPeptideRx EditorialLast reviewed:

Arkansas is the one state in this file whose legislature answered this question for one kind of supplier and left the other blank, so both of the sentences people write about it are wrong. Act 961 of 2025 expressly authorises an outsourcing facility to sell a compounded product to an Arkansas-licensed healthcare provider for administration to a patient in a medical clinic. On the 503A pharmacy side there is no human provision at all — every office-use reference in the Board’s rule book is veterinary. So "Arkansas permits office use" is wrong for pharmacies and right for outsourcing facilities, and "Arkansas prohibits office use" is wrong for outsourcing facilities. The split is the answer.

The governing rule

Arkansas’s office-use position is set by Ark. Code § 17-92-121(b)(1) (Act 961 of 2025); 17 CAR § 160-2201(d). The text below is quoted verbatim; everything outside a quote block is our summary of it, and the two are kept visually separate on purpose.

Ark. Code § 17-92-121(b)(1) — the 503B permission, created by Act 961 of 2025
An outsourcing facility of legend drugs and controlled substances that compounds a product may sell a compounded product to: (A) An Arkansas-licensed retail pharmacy for dispensing to a patient; (B) An Arkansas-licensed healthcare facility for administration to a patient; or (C) An Arkansas-licensed healthcare provider, such as a physician or nurse practitioner, for administration to a patient in a medical clinic.
17 CAR § 160-2601(8)(E) — the entry barrier, and it is in the definitions
have an Arkansas-licensed pharmacist-in-charge on staff a minimum of thirty-two (32) hours per week
17 CAR § 160-2201(d) — the 503A compounding rule, which routes to federal law
shall comply with all requirements of Section 503A of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.S. § 353a

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

One side answered, one side silentMedium confidence
The 503B limb is express and recent: a facility may sell compounded product to a retail pharmacy for dispensing, to a healthcare facility for administration, or to a named licensed provider for administration in a medical clinic. The 503A limb has no human equivalent — every office-use reference in the Board’s rule book sits inside the veterinary subsection. Nothing prohibits 503A office use in terms; nothing authorises it either.The 503B permission carries no federal condition on its face. The 503A compounding rule, by contrast, requires compliance with the federal compounding section — so the two limbs are different in kind as well as in outcome.
The 32-hour in-building pharmacist, which is the real cost of entryHigh confidence
An outsourcing facility must have an Arkansas-licensed pharmacist-in-charge on staff a minimum of thirty-two hours a week, and the application hardens that: the person must be an employee rather than a consultant, and must be present at the physical location stated on the application. That is a near-full-time in-state hire inside the facility’s own building.It sits in the definitions section rather than in the permit rule, which is why it is so often missed. Any page quoting Arkansas’s permit fee as the cost of entry understates it by orders of magnitude — the fee is the small number.
No legend, and a condition that points at nothingHigh confidence
Arkansas prescribes no office-use label legend for humans — searches for the usual phrases return nothing. Worth flagging: the veterinary grant requires compliance "in accordance with the labeling requirements", and no such requirements are stated anywhere in the rule. The condition has no referent.
QuantityHigh confidence
No cap applies to the human limbs — searches for an inordinate-amount standard, a reasonable-quantity standard and an anticipatory-compounding phrase all return nothing. The only numeric limit in the area is the veterinary emergency re-dispense, capped at seven days.
Entity or person — the clearest split in this file, and no credential covers bothHigh confidence
For controlled items the seller must verify the federal registration for that specific address, and the state rule reaches natural persons and entities alike, requiring a separate registration for each principal place of business at one general physical location. For non-controlled items the qualifying party under the 2025 Act is the named Arkansas-licensed provider, and the practice exemption at § 17-92-102(a) runs to natural persons only — and is an emergency-bag exemption rather than an office-stock one. A mixed order can therefore need two different names, and no single Arkansas credential covers both.Two gaps in that structure should not be papered over. Nurse practitioners are named inside the 2025 Act but appear in neither the practice exemption nor the shipment-authorisation list. And that list names a physician licensed by the Arkansas State Medical Board specifically, rather than a prescriber generally.
No state controlled-substance registration, and the rules sit elsewhereHigh confidence
The Arkansas Code sections that would carry a state controlled-substance registration are marked reserved, so no such registration exists. The controlled-substance rules belong to the health department rather than to the pharmacy board, which is where a reader searching the pharmacy corpus will fail to find them.
Last change, and why no effective date is published hereMedium confidence
Act 961 was approved on 21 April 2025. Its effective date is bounded rather than pinned: the act carries no emergency clause, so it took effect ninety-one days after the session adjourned, which places it between May 2025 and January 2026. No precise date is published on this page because none was established.

Arkansas at a glance

Arkansas office-use compounding summary, reviewed 2026-08-30
Human office useSilent for pharmacies; expressly permitted for outsourcing facilities
Sterile preparationsNone on the 503A limb; the 503B definition names sterile human drugs
Quantity capNone for humans
Mandatory label legendNone for humans
Board reportingNone for office use
Last changeAct 961 approved April 2025; effective date bounded, not pinned
Governing ruleArk. Code § 17-92-121(b)(1) (Act 961 of 2025); 17 CAR § 160-2201(d)

Receiving 503B office stock in Arkansas

Arkansas licenses outsourcing facilities, but not as a category — it is a tick-box on the wholesale distribution application, with a licence prefix and no fee line of its own. The real barrier is not the fee at all.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What Arkansas asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inMedium confidence
A wholesale distribution licence, selected as a 503B outsourcer on the application. The rule states it directly: the facility shall be licensed under the wholesale distribution rules as a 503B outsourcer. On the form it is a checkbox under type of business, the licence carries a wholesale-distribution prefix, and the twenty-one-item fee schedule contains no line for it. The Board now sits inside the Department of Health.The fee is stated three different ways across the state’s own sources — the rule, the statute and the application form each give a different figure — so no single number is published here. And the fee is not the constraint: see the 32-hour pharmacist-in-charge requirement above.
Does your practice need a permit?High confidence
No, and none exists. The 2025 Act makes the provider’s own professional licence the qualifying credential — the facility may sell to an Arkansas-licensed healthcare provider, and that licence is what qualifies them.
Administer vs dispenseHigh confidence
The Act draws the line explicitly and differently for each recipient: a retail pharmacy takes product for dispensing to a patient, while a healthcare facility and a licensed provider take it for administration. A provider receiving office stock under limb (C) is authorised to administer it, not to dispense it.
Scheduled (controlled) stockHigh confidence
There is no Arkansas controlled-substance registration to obtain — the code sections are reserved — and the controlled-substance rules belong to the health department rather than the pharmacy board. For controlled items the operative check is the federal registration for that specific address, which the seller must verify.

How to check a facility’s credential before you order is set out in how to place an office-use order.

The federal layer still applies

Whatever Arkansas law allows, federal law applies on top of it and is not satisfied by state permission. 21 U.S.C. § 353a conditions the federal compounding exemptions on a drug being compounded for an identified individual patient on receipt of a valid prescription order. A state rule cannot create a federal safe harbour, and several state rules say so in their own text. The separate federal pathway for non-patient-specific office stock is the 503B outsourcing facility — the differences are set out in 503A vs 503B.

For how Arkansas compares with the other states reviewed, see the state-by-state comparison.

What this page does not establish

  • Whether Arkansas ever had a human office-use provision that was deleted at codification is not established. We proved there is no current one and found no evidence one existed, but the pre-codification text was not read end to end. If a human clause was once deleted, "silent by omission" becomes "silent by repeal", which is a materially different and more citable finding.
  • The Arkansas State Medical Board was not checked at all. The pharmacy corpus contains no physician-dispensing registration, but a medical-board credential would sit outside everything read for this page. It is the highest-value unchecked agency here.
  • Board minutes for 2025 and 2026 are scanned images with no text layer and were not put through character recognition, so any board discussion of human office stock is outside what this page covers.
  • The outsourcing-facility fee is stated three different ways across the rule, the statute and the application form, and the licensing rule contradicts itself on whether renewal is annual or biennial. No single figure or period is published here.
  • If you check Arkansas citations yourself, note that the rules were renumbered on 1 January 2025 — cite them with the current prefix, and be aware that one rule repealed in June 2026 is still listed in the Board’s own current table of contents.
  • We searched no case law or attorney-general opinions for this state, and search engines were unavailable when it was researched. Read nothing into that silence — it means we have not looked, not that nothing is there.

Sources

Primary sources, fetched directly from the issuing body. No secondary summaries.

  1. [1]Act 961 of 2025 (HB1801), enrolled — the enacted text creating Ark. Code § 17-92-121
  2. [2]Ark. Code § 17-92-121 — outsourcing facility sales, as codified
  3. [3]17 CAR § 160-2201 — standards for compounding, routing 503A work to the federal statute at (d)
  4. [4]17 CAR § 160-2601 — definitions, including the outsourcing-facility staffing requirement
  5. [5]21 U.S.C. § 353a — Pharmacy compounding (Cornell LII)